RecoMed has received an undisclosed investment from Japanese pharmaceutical firm Eisai, marking the healthtech company's largest funding round to date.
RecoMed is an online healthcare marketplace and booking platform in SA that connects practitioners, patients, and other stakeholders in the healthcare ecosystem. The company manages more than 100,000 bookings a month.
“Eisai recently entered the African market and has a clear vision around the value of digital platforms that provide people with easy access to healthcare, which aligns with our own,” says Sheraan Amod, founder and CEO of RecoMed.
“The investment will enhance our technology, drive awareness of the platform, and build a more robust digital healthcare journey for patients. We are deeply committed to improving the patient treatment journey and overall outcomes across a range of diseases, and with our initial focus on breast cancer, we are firmly on the road to achieving this goal.”
Shin Ujiie, vice president for corporate strategy at Eisai, adds, “We engaged with RecoMed because they align with our goal to use digital platforms and technologies to streamline the entire patient journey, thus ultimately alleviating people’s anxiety over health and reducing health disparities."
“Healthcare is complex and, therefore, can be difficult to access. We have sought to change this narrative, making health an easily accessible priority for everyone. RecoMed has proven itself as a leader in this space, and their innovative approach to digital health services makes them the perfect partner on our journey.”
RecoMed works with pharmacies, clinics, primary care, and hospital groups. The network allows practitioners, in partnership with medical aids, insurers, pharmaceutical companies, and other organisations, to gain access to a growing pool of patients.
Enterprises can white-label RecoMed, using it for bookings and telehealth appointments. The health tech firm also provides an e-pharmacy service, allowing patients to upload prescriptions and opt to collect them from a participating pharmacy or have them delivered.
“The funding from Eisai will ensure we continue to improve access and healthcare delivery for patients by cutting down the time it takes them to book the services they need,” notes Amod.
“We facilitate more than R500 million in healthcare spending annually by making patient care simple for our more than 1.5 million users.”
The article was first published on ITWeb.co.za.